Antifungal effects of dibenzofuran derivatives against multi-azole resistant Candida albicans
Bioorganic Chemistry · 2026-08 · 178 · 109971
DOI: 10.1016/j.bioorg.2026.109971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-08. Verfasst von Oluwatosin Oluwaseun Faleye und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic of Korea. Hauptthemen laut MEDLINE: Antifungal Agents, Candida albicans, Drug Resistance, Fungal, Dibenzofurans. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Ministry of Health and Welfare, Ministry of Science and ICT, South Korea, Korea Health Industry Development Institute.
Abstract (Originalsprache)
The emergence of multi-azole resistant Candida albicans strains poses a major therapeutic challenge, largely due to their biofilm formation and hyphal development. In this study, the antifungal and antivirulence properties of 18 dibenzofuran derivatives were evaluated against a multi-azole resistant C. albicans strain. Dibenzofuran-4‑boronic acid (DBFBA) and dibenzofuran-2-carboxaldehyde (DBFC) emerged as the most active compounds, with DBFBA exhibiting the MIC of 30 μg/mL. Both compounds inhibited 94-98% biofilm at 10 μg/mL, suppressed hyphal morphogenesis and impaired cell aggregation at sub-MICs (5 μg/mL). DBFBA and related boronic acid derivatives further demonstrated potent antifungal activities across clinically relevant Candida strains, such as C. glabrata, C. parapsilosis, and C. auris. Both compounds induced intracellular reactive oxygen species (ROS) and increased cellular ergosterol levels, supporting a mechanism distinct from direct ergosterol inhibition. Serial passage experiment revealed low propensity for resistance development compared with fluconazole. Drug interaction studies revealed synergy with terbinafine for both compounds. DBFBA additionally downregulated the virulence-associated iron acquisition gene RBT5. Importantly, both compounds showed minimal toxicity in HepG2 cells, Caenorhabditis elegans and Raphanus sativus models. In silico ADME analysis further supported both compounds favorable drug-like profile. These findings position dibenzofuran derivatives, particularly DBFBA, as promising antifungal candidates against azole-resistant Candida species.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic of Korea.
- School of Chemical Engineering, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic of Korea. Electronic address: jinhlee@ynu.ac.kr.
- School of Chemical Engineering, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic of Korea. Electronic address: jtlee@ynu.ac.kr.
Förderung
- Ministry of Health and Welfare
- Ministry of Science and ICT, South Korea
- Korea Health Industry Development Institute
- National Research Foundation of Korea
Zitieren
APA
Faleye, O. O., Mukhles, M. B., Boya, B. R., Kim, Y. G., Lee, J. H., & Lee, J. (2026). Antifungal effects of dibenzofuran derivatives against multi-azole resistant Candida albicans. Bioorganic Chemistry, 178, 109971. https://doi.org/10.1016/j.bioorg.2026.109971
Vancouver
Faleye OO, Mukhles MB, Boya BR, Kim YG, Lee JH, Lee J. Antifungal effects of dibenzofuran derivatives against multi-azole resistant Candida albicans. Bioorganic Chemistry. 2026;178:109971. doi:10.1016/j.bioorg.2026.109971
BibTeX
@article{Faleye2026,
author = {Faleye, Oluwatosin Oluwaseun and Mukhles, Muntaha Binte and Boya, Bharath Reddy and Kim, Yong-Guy and Lee, Jin-Hyung and Lee, Jintae},
title = {Antifungal effects of dibenzofuran derivatives against multi-azole resistant Candida albicans},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {178},
pages = {109971},
doi = {10.1016/j.bioorg.2026.109971}
}
EUVIMED